Evidence map›Paper›PMID 38152039›Full record

ArticleHaematologica2024

Efficacy of combined low-dose ruxolitinib and cyclosporine in murine immune bone marrow failure.

Xingmin Feng, Ash Lee Manley, Zhijie Wu, Haoran Li, Shouguo Gao, Jibran Durrani, Nidhi Aggarwal, Hiroki Mizumaki, Jichun Chen, Neal S Young and 1 more

Open access · goldAbstract readLetter
In one paragraph

Article in Haematologica, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Xingmin FengHematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD. fengx2@nhlbi.nih.gov.
Ash Lee ManleyHematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.
Zhijie WuHematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.
Haoran LiHematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.
Shouguo GaoHematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.
Jibran DurraniHematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.
Nidhi AggarwalHematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.
Hiroki MizumakiHematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.
Jichun ChenHematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.
Neal S YoungHematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.
Emma M GroarkeHematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD.
National Institutes of Health · USNational Heart Lung and Blood Institute · US

Funding

Pathogenesis And Treatment Of Aplastic AnemiaZIAHL002315 · NHLBI · NATIONAL HEART, LUNG, AND BLOOD INSTITUTE · PI YOUNG, NEAL S · 2009 to 2025
$60.1M
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

CyclosporineNitrilesPyrazolesPyrimidinesAnimalsBone Marrow Failure DisordersDisease Models, AnimalDrug Therapy, CombinationMiceCyclosporineNitrilesPyrazolesPyrimidinesruxolitinib

Identifiers

PMID38152039
PMCPMC11063833
OpenAlexW4390343712

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.